A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection
Clinical trial NCT02243280 · COMPLETED
Trial details
- NCT number
- NCT02243280
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-02-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.